Phase II trial of AZP 531 in patients with type I diabetes mellitus

Trial Profile

Phase II trial of AZP 531 in patients with type I diabetes mellitus

Planning
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs AZP 531 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2014 New trial record
    • 10 Sep 2014 This trial is expected to be initiated in the last quarter of 2014, according to an Alize Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top